Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus

The Journal of Clinical Investigation
J E GerichP H Korsham

Abstract

To examine whether abnormal pancreatic alpha-cell function found in human diabetes mellitus may represent a selective insensitivity to glucose, plasma glucagon responses to hyperglycemia and elevation of plasma free fatty acid levels (both known suppressors of glucagon secretion) were compared in juvenile-onset, insulin-requiring diabetic subjects, and in normal nondiabetic subjects. In the latter, both elevation of plasma free fatty acid levels induced by heparin administration of hyperglycemia produced by intravenous infusion of glucose resulted in a comparable 30--40% suppression of circulating glucagon levels (P less than 0.01). In the diabetic subjects, glucagon suppression by hyperglycemia (less than 20%) was less than that occurring in normal subjects (P less than 0.01), even when accompanied by infusion of supraphysiologic amounts of insulin. However, suppression of glucagon levels by elevation of plasma free fatty acids in the diabetic group was similar to that found in normal subjects and of comparable magnitude to that due to hyperglycemia in the normal subjects. These results thus demonstrate a selective impairment of the diabetic alpha-cell response to glucose and provide further evidence for the presence of an abn...Continue Reading

References

Mar 1, 1975·The Journal of Clinical Endocrinology and Metabolism·J E GerichD M Bier
Nov 1, 1975·The Journal of Clinical Investigation·P RaskinR H Unger
Dec 1, 1975·Diabetologia·A S LuyckxP J Lefebvre
Dec 30, 1972·Lancet·K D Buchanan, A M McCarroll
Aug 1, 1974·European Journal of Clinical Investigation·E O Balasse, M A Neef
Apr 1, 1974·The Journal of Clinical Investigation·J T BraatenR H Unger
Apr 1, 1973·The Journal of Clinical Investigation·R P Robertson, D Porte
May 1, 1974·The Journal of Clinical Investigation·J E GerichC Noacco
Feb 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·A S Luyckx, P J Lefebvre
Sep 1, 1971·The Journal of Clinical Investigation·W A MüllerR H Unger
Apr 1, 1970·The Journal of Clinical Investigation·R H UngerA M Eisentraut
Aug 19, 1971·The New England Journal of Medicine·R H Unger

❮ Previous
Next ❯

Citations

Feb 1, 1983·Diabetologia·P R Bratusch-Marrain
Apr 1, 1980·Prostaglandins and Medicine·S A MetzR P Robertson
Dec 27, 1979·The New England Journal of Medicine·R P Robertson, S A Metz
Dec 1, 2015·Diabetes Technology & Therapeutics·Ananda Basu, Rita Basu
Mar 1, 1983·Metabolism: Clinical and Experimental·C AsplinJ P Palmer
Nov 1, 1978·Metabolism: Clinical and Experimental·R H Unger
Dec 1, 1979·Australian and New Zealand Journal of Medicine·F P Alford, D J Chisholm
Jan 1, 1976·Clinical Endocrinology·J E GerichP H Forsham
Sep 1, 1993·Metabolism: Clinical and Experimental·P ValensiJ R Attali
Mar 10, 2017·Physiological Reviews·T D MüllerM H Tschöp
Jun 1, 2018·The Journal of Endocrinology·S J BrandtT D Müller
Aug 9, 2018·Pharmacological Reviews·T D MüllerM H Tschöp
Aug 1, 1979·Archives of Disease in Childhood·J W Farquhar
Jan 1, 1995·Journal of Veterinary Internal Medicine·M M ChristopherM E Peterson
Jan 16, 2020·International Journal of Molecular Sciences·Timo D Müller, Kirk Habegger
Sep 24, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Lijun ChenRoger H Unger
Sep 20, 2018·Journal of Internal Medicine·S J BrandtK Stemmer
Nov 11, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Elliot Sternthal
Jul 31, 2019·International Journal of Molecular Sciences·Norikiyo HonzawaTadahiro Kitamura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.